Clinical Trial Update: BMS-247550 in Treating Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of BMS-247550 for metastatic colorectal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• BMS-247550

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED